These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 18069998

  • 1. Reduced positive affect (anhedonia) predicts major clinical events following implantation of coronary-artery stents.
    Denollet J, Pedersen SS, Daemen J, de Jaegere P, Serruys PW, van Domburg RT.
    J Intern Med; 2008 Feb; 263(2):203-11. PubMed ID: 18069998
    [Abstract] [Full Text] [Related]

  • 2. Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: a Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry substudy.
    Pedersen SS, Lemos PA, van Vooren PR, Liu TK, Daemen J, Erdman RA, Smits PC, Serruys PW, van Domburg RT.
    J Am Coll Cardiol; 2004 Sep 01; 44(5):997-1001. PubMed ID: 15337209
    [Abstract] [Full Text] [Related]

  • 3. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality.
    Pedersen SS, Denollet J, Ong AT, Sonnenschein K, Erdman RA, Serruys PW, van Domburg RT.
    Eur J Cardiovasc Prev Rehabil; 2007 Feb 01; 14(1):135-40. PubMed ID: 17301639
    [Abstract] [Full Text] [Related]

  • 4. Type-D personality predicts chronic anxiety following percutaneous coronary intervention in the drug-eluting stent era.
    Spindler H, Pedersen SS, Serruys PW, Erdman RA, van Domburg RT.
    J Affect Disord; 2007 Apr 01; 99(1-3):173-9. PubMed ID: 17049996
    [Abstract] [Full Text] [Related]

  • 5. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S, Burzotta F, Trani C, Todaro D, Talarico G, Porto I, Leone AM, Niccoli G, Mazzari MA, Mongiardo R, Schiavoni G, Crea F.
    Minerva Cardioangiol; 2008 Feb 01; 56(1):35-42. PubMed ID: 18432167
    [Abstract] [Full Text] [Related]

  • 6. Social inhibition modulates the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era.
    Denollet J, Pedersen SS, Ong AT, Erdman RA, Serruys PW, van Domburg RT.
    Eur Heart J; 2006 Jan 01; 27(2):171-7. PubMed ID: 16246826
    [Abstract] [Full Text] [Related]

  • 7. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C, Kim SH, Suh J, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ.
    Catheter Cardiovasc Interv; 2008 Apr 01; 71(5):594-8. PubMed ID: 18311841
    [Abstract] [Full Text] [Related]

  • 8. Reduced positive affect (anhedonia) is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry.
    Damen NL, Pelle AJ, Boersma E, Serruys PW, van Domburg RT, Pedersen SS.
    Eur J Prev Cardiol; 2013 Feb 01; 20(1):127-34. PubMed ID: 22345679
    [Abstract] [Full Text] [Related]

  • 9. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C, Sudre A, Lemesle G, Maréchaux S, Broucqsault D, Hennache B, Bauters C, Lablanche JM.
    Cardiovasc Revasc Med; 2009 Feb 01; 10(3):144-50. PubMed ID: 19595394
    [Abstract] [Full Text] [Related]

  • 10. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY, Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Park SW, Park SJ.
    J Am Coll Cardiol; 2009 Aug 25; 54(9):853-9. PubMed ID: 19695467
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL, SPIRIT III Investigators.
    Circulation; 2009 Feb 10; 119(5):680-6. PubMed ID: 19171853
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V, Tsyvine D, Cohen DJ, Pencina M, Dubin J, Dehghani H, Kleiman NS, Cutlip DE.
    Catheter Cardiovasc Interv; 2009 Jun 01; 73(7):874-80. PubMed ID: 19180665
    [Abstract] [Full Text] [Related]

  • 18. Anhedonia as predictor of clinical events after acute coronary syndromes: a 3-year prospective study.
    Leroy M, Loas G, Perez-Diaz F.
    Compr Psychiatry; 2010 Jun 01; 51(1):8-14. PubMed ID: 19932820
    [Abstract] [Full Text] [Related]

  • 19. Long-term (>3 Years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry).
    Planer D, Beyar R, Almagor Y, Banai S, Guetta V, Miller H, Kornowski R, Brandes S, Krakover R, Solomon M, Lotan C.
    Am J Cardiol; 2008 Apr 01; 101(7):953-9. PubMed ID: 18359314
    [Abstract] [Full Text] [Related]

  • 20. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.
    Yan BP, Ajani AE, New G, Duffy SJ, Farouque O, Shaw J, Sebastian M, Lew R, Brennan A, Andrianopoulos N, Reid C, Clark DJ, Melbourne Interventional Group Investigators.
    Int J Cardiol; 2008 Nov 28; 130(3):374-9. PubMed ID: 18706719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.